Spyre Therapeutics, Inc. (SYRE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $2.55M2016: $4.10M2017: $5.74M2018: $10.31M2019: $23.10M2020: $21.79M2021: $25.98M2022: $20.84M2023: $73.29M2024: $90.68M2025: $62.55M$62.55M
2015Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$62.55M-31.0%
2024$90.68M+23.7%
2023$73.29M+251.7%
2022$20.84M-19.8%
2021$25.98M+19.3%
2020$21.79M-5.7%
2019$23.10M+124.1%
2018$10.31M+79.6%
2017$5.74M+40.1%
2016$4.10M+60.7%
2015$2.55M